Exploiting antitumor immunity to overcome relapse and improve remission duration

Plasmacytoid Dendritic Cells: Recent Progress and Open Questions

(2011) Boris Reizis et al.   Annual Review of Immunology

How to improve the immunogenicity of chemotherapy and radiotherapy

(2011) Yuting Ma et al.   CANCER AND METASTASIS REVIEWS

Immunosurveillance in human non-viral cancers

(2011) Wolf Herman Fridman et al.   CURRENT OPINION IN IMMUNOLOGY

IFN-α as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use

(2011) Paola Rizza et al.   Expert Review of Vaccines

Signaling of c-kit in dendritic cells influences adaptive immunity

(2010) Prabir Ray et al.   Annals of the New York Academy of Sciences

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

(2010) Claude Preudhomme et al.   NEW ENGLAND JOURNAL OF MEDICINE

Natural Killer Cell IFN-  Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor-Bearing Patients

(2009) C. Menard et al.   CANCER RESEARCH

The Antitumor and Immunoadjuvant Effects of IFN-  in Combination with Recombinant Poxvirus Vaccines

(2009) K. W. Hance et al.   CLINICAL CANCER RESEARCH

IFN-  Enhances Peptide Vaccine-Induced CD8+ T Cell Numbers, Effector Function, and Antitumor Activity

(2009) A. G. Sikora et al.   JOURNAL OF IMMUNOLOGY

Direct Expansion of Human Allospecific FoxP3+CD4+ Regulatory T Cells with Allogeneic B Cells for Therapeutic Application

(2009) L. C. Chen et al.   JOURNAL OF IMMUNOLOGY

Impaired interferon signaling is a common immune defect in human cancer

(2009) R. J. Critchley-Thorne et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recombinant interferon-α2b improves immune response to hepatitis B vaccination in haemodialysis patients: Results of a randomised clinical trial

(2009) María E. Miquilena-Colina et al.   VACCINE

A Randomized, Phase II Study of Preoperative plus Postoperative Imatinib in GIST: Evidence of Rapid Radiographic Response and Temporal Induction of Tumor Cell Apoptosis

(2008) John C. McAuliffe et al.   ANNALS OF SURGICAL ONCOLOGY

Optimizing the dose of imatinib for treatment of gastrointestinal stromal tumours: Lessons from the phase 3 trials

(2008) Shreyaskumar Patel et al.   EUROPEAN JOURNAL OF CANCER

Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group

(2008) Michael C. Heinrich et al.   JOURNAL OF CLINICAL ONCOLOGY

Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression

(2008) Lei L Chen et al.   MODERN PATHOLOGY